Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

437.15 +2.63 (+0.61%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
68 69 Next >
News headline image
3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results ↗
Via The Motley Fool
News headline image
3 Monster Stocks in the Making to Buy Right Now ↗
Via The Motley Fool
News headline image
3 Top Growth Stocks to Buy in the Second Half of 2025 ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
3 Cash-Burning Stocks Walking a Fine Line
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even... 
Via StockStory
Topics Bankruptcy Economy
News headline image
Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
My 3 Top Stocks to Buy in a Market That's Highly Volatile (Again) ↗
Via The Motley Fool
Topics Artificial Intelligence Energy World Trade
News headline image
The Best Stocks to Invest $1,000 in Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
10 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
With just a little bit of a deeper look, these businesses are positioned for long-term growth. 
Via The Motley Fool
News headline image
Motley Fool Co-Founder David Gardner Reviews Stock Picks ↗
Via The Motley Fool
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Via Investor Brand Network
News headline image
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:VRTX),(NASDAQ:IBRX),(NASDAQ:CRSP),(NASDAQ:CTMX) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
News headline image
Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz ↗
Via The Motley Fool
Topics Stocks
News headline image
Vertex to Announce Second Quarter 2025 Financial Results on August 4th
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:REGN),(NASDAQ:VRTX),(OTCQX:RHHBY),(NYSE:MRK) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
News headline image
3 No-Brainer Stocks to Buy in July ↗
Via The Motley Fool
News headline image
The Best Stocks to Invest $1,000 In Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence Government
News headline image
Vertex Pharma’s New Cystic Fibrosis Drug Granted Approval By EU ↗
Vertex announced on Tuesday that eligible patients in Ireland, Denmark, and Germany will have access to Alyftrek shortly after receiving regulatory approval from the relevant authorities. 
Via Stocktwits
News headline image
$100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
How Do Investors Really Feel About Vertex Pharmaceuticals? ↗
 
Via Benzinga
News headline image
3 S&P 500 Stocks with Mounting Challenges
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Vertex Pharmaceuticals Unusual Options Activity ↗
 
Via Benzinga
News headline image
Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
3 Unpopular Stocks Facing Headwinds
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering ↗
FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era exemption on federally funded research 
Via Benzinga
News headline image
Friday's session: gap up and gap down stock in the S&P500 index ↗
Let's have a look at what is happening on the US markets on Friday. Below you can find the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
2 Growth Stocks to Buy and Hold for 10 Years ↗
Via The Motley Fool
Topics Artificial Intelligence Economy World Trade
News headline image
A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts ↗
 
Via Benzinga
News headline image
3 Growth Stocks You Can Buy Right Now Without Any Hesitation ↗
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
68 69 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.